[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366508-105":59,"doc-detail-366508-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glucose-metabolic-reprogramming-in-colorectal-cancer-from-mechanisms-to-targeted-therapy-approaches","Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches","","Glucose metabolic reprogramming drives colorectal cancer (CRC) initiation, progression, and chemoresistance by supplying energy and essential nutrients and by enabling malignant proliferation and metastasis. This review summarizes how genetic and protein changes alter glucose metabolism and coordinate dual metabolic programs with lipid or amino acid pathways. It also evaluates targeted metabolic therapy strategies and highlights mechanisms underlying drug resistance to inform improved treatment outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glucose-metabolic-reprogramming-in-colorectal-cancer-from-mechanisms-to-targeted-therapy-approaches/366508/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glucose-metabolic-reprogramming-in-colorectal-cancer-from-mechanisms-to-targeted-therapy-approaches/366508.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is glucose metabolic reprogramming important in colorectal cancer?","Question",{"text":112,"@type":113},"It fuels CRC cells with energy and essential nutrients, supporting proliferation and metastasis. It is also linked to tumor resistance to chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review cover about metabolic reprogramming?",{"text":117,"@type":113},"It outlines the role of glucose metabolic reprogramming in CRC onset and development. It further discusses progress on dual reprogramming involving glucose with lipid metabolism or amino acid metabolism.",{"name":119,"@type":110,"acceptedAnswer":120},"How are targeted metabolic therapies expected to help patients?",{"text":121,"@type":113},"Targeted strategies that inhibit glucose metabolic reprogramming, including metabolic inhibitors and combinations with immunotherapy, show potential to slow CRC progression and improve treatment outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366508,1790203006,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Medicine  \n|  REVIEW  OPEN ACCESS \u003Cbr>Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches\u003Cbr>Runkai Zhou1  | Fazhi Wang1 | Jiazhe Wen2 | Xuefeng Zhou3 | Yugang Wen1\u003Cbr>1Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China | 2School of Basic Medical Sciences, Fudan University, Shanghai, China | 3Department of Oncology, The Dongtai Hospital of Nantong University, Dongtai, Jiangsu, China Correspondence: Xuefeng Zhou ([dtzxf4490@163.com](dtzxf4490@163.com)) | Yugang Wen ([wenyg1502@hotmail.com](wenyg1502@hotmail.com))\u003Cbr>Received: 5 November 2024 | Revised: 13 August 2025 | Accepted: 19 August 2025\u003Cbr>Funding: This work was supported by the National Natural Science Foundation of China (81972215 to Yugang Wen) .\u003Cbr>Keywords: colorectal cancer | glucose metabolism | metabolic reprogramming | targeted therapy |\n| --- |\n| ABSTRACT\u003Cbr>Background: Colorectal cancer (CRC) is one of the most common malignant tumors, and its morbidity ranks third among all cancers, with a trend toward younger patients. Metabolic reprogramming, a unique metabolic mode in tumor cells, is closely related to the occurrence and development of CRC. Numerous studies have confirmed that many genetic and protein changes can regulate cellular metabolic reprogramming, of which changes in glucose metabolism have the greatest impact. These aberrant metabolic processes provide energy and essential nutrients to CRC cells, promoting their proliferation and metastasis and influencing tumor resistance. The purpose of this review is to outline the role of glucose metabolic reprogramming in the onset and development of CRC, discuss the research progress in the dual reprogramming of glucose metabolism and lipid metabolism or glucose metabolism and amino acid metabolism, and address the issues of targeted metabolism therapy and drug resistance. Methods: We searched PubMed for review articles published in English between January 1, 2015, and April 26, 2024, which included “Colorectal Neoplasms” with “Metabolic Reprogramming” OR “Glucose Metabolism Disorders” OR “The Warburg Effect” OR “Targeted Therapy.” Subsequently, the literature was classified, organized, and summarized. Various types of studies were integrated and compiled into this review. Additionally, mechanism diagrams were drawn to facilitate the understanding of this study. The figures were created using [BioRender.com](BioRender.com) and has obtained the official publication license.\u003Cbr>Conclusions: Glucose metabolic reprogramming serves as a pivotal driver of CRC initiation, progression, and chemoresistance, while its crosstalk with lipid or amino acid metabolic reprogramming further amplifies the malignant phenotype of CRC. Targeted therapeutic strategies aiming at glucose metabolic reprogramming (such as metabolic inhibitors, combination with immunotherapy) and related clinical research have demonstrated potential for inhibiting CRC progression and improving treatment outcomes. |\n|  |\n| Abbreviations: 2-DG, 2-Deoxy-D-glucose; 4-OI, 4-Octyl itaconate; ADMA, asymmetric dimethylarginine; AF9, ALL1-fused gene from chromosome 9; AMPK, AMP-activated protein kinase; ARL15, ADP-ribosylation factor-like 15; ART1, arginine ADP-ribosyltransferase 1; ATF4, transcription factor 4; ChREBP, carbohydrate response element binding protein; CRC, colorectal cancer; CRMP2, collapsin response mediator protein 2; DC, dendritic cells; FABP4, fatty-acid-binding protein 4; FBP, fructose-1,6-bisphosphate; FOXM1, Forkhead box M1; G6PD, glucose-6-phosphate dehydrogenase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GLUT, glucose transporter; GPR37, G protein-coupled receptor 37; GSK-3, glycogen synthase kinase-3; HIF1-α, hypoxia-inducible factor 1 alpha; HK2, hexokinase 2; HKDC1, hexokinase domain component 1; LDH, lactate dehydrogenase; MnSOD, manganese superoxide dismutase; OXPHOS, oxidative phosphorylation; PBX","cbCaiq6RLvWokGjD","https://ap.wps.com/l/cbCaiq6RLvWokGjD","pdf",1348088,18,"English","# Abstract\n## Background\n## Methods\n## Conclusions\n# Introduction\n## Risk factors and epidemiology\n## Screening and treatment challenges","[{\"question\":\"Why is glucose metabolic reprogramming important in colorectal cancer?\",\"answer\":\"It fuels CRC cells with energy and essential nutrients, supporting proliferation and metastasis. It is also linked to tumor resistance to chemotherapy.\"},{\"question\":\"What does the review cover about metabolic reprogramming?\",\"answer\":\"It outlines the role of glucose metabolic reprogramming in CRC onset and development. It further discusses progress on dual reprogramming involving glucose with lipid metabolism or amino acid metabolism.\"},{\"question\":\"How are targeted metabolic therapies expected to help patients?\",\"answer\":\"Targeted strategies that inhibit glucose metabolic reprogramming, including metabolic inhibitors and combinations with immunotherapy, show potential to slow CRC progression and improve treatment outcomes.\"}]","Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches | PDF",1790165862,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c717a4b7ede964429e3b000b404a408.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cfc311a2860504ba3a79d3b56ea2f8a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3390e1a24b321bb4f6c60c9e91d2ac50.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd6cc37f3946c6d364e3567a8c89a6d3.webp",980,1287]